Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine

Lucia Taramasso, Franco Maggiolo, Daniela Valenti, Sabrina Blanchi, Federica Centorrino, Laura Comi, Antonio Di Biagio

Open source

DOI: 10.1097/qai.0000000000003594
Published: 2025-04-15
Container: JAIDS Journal of Acquired Immune Deficiency Syndromes
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qai.0000000000003594,
  title = {Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine},
  author = {Lucia Taramasso and Franco Maggiolo and Daniela Valenti and Sabrina Blanchi and Federica Centorrino and Laura Comi and Antonio Di Biagio},
  year = {2025},
  journal = {JAIDS Journal of Acquired Immune Deficiency Syndromes},
  doi = {10.1097/qai.0000000000003594},
  url = {https://doi.org/10.1097/qai.0000000000003594}
}

RIS

TY  - JOUR
TI  - Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine
AU  - Lucia Taramasso
AU  - Franco Maggiolo
AU  - Daniela Valenti
AU  - Sabrina Blanchi
AU  - Federica Centorrino
AU  - Laura Comi
AU  - Antonio Di Biagio
PY  - 2025
JO  - JAIDS Journal of Acquired Immune Deficiency Syndromes
DO  - 10.1097/qai.0000000000003594
UR  - https://doi.org/10.1097/qai.0000000000003594
ER  -

APA

Taramasso, L., Maggiolo, F., Valenti, D., Blanchi, S., Centorrino, F., Comi, L., & Biagio, A. D. (2025). Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000003594

Source records

crossref · retrieved 2026-09-26T22:25:40.157Z